Athira Pharma, Inc.(ATHA)

盘后0.5660-0.01-1.22%19:32 EST

0.5730+0.0229+4.16%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Athira Pharma, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.athira.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Athira Pharma, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology，Inc.，并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司，致力于开发小型药物分子来恢复神经元健康并阻止神经变性。凭借公司的候选产品，它旨在通过其新颖的作用机制提供快速的认知改善，并改变神经系统疾病的病程。
- 01-02 13:00
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 01-02 13:00
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 01-02 13:00
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 01-02 13:00
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2024-11-14
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-11-08
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-07
  超过5%披露
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 2024-10-31
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 2024-10-25
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-18
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-10-08
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-09-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-09-05
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2024-09-03
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report